Sarcoidosis occurring after interferon-α therapy for chronic hepatitis C

Report of two cases

Atsushi Hirano, Mikio Kataoka, Yasunari Nakata, Katsuyuki Takeda, Takayuki Kamao, Junichi Hiramatsu, Goro Kimura, Yasushi Tanimoto, Arihiko Kanehiro, Mitsune Tanimoto

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We report two patients who were diagnosed with sarcoidosis after receiving interferon (IFN)-α therapy for chronic hepatitis C, and conduct a review the relevant literature. The first patient was a 52-year-old female who developed multiple subcutaneous nodules 2 months after finishing IFN-α therapy. A skin biopsy from subcutaneous nodules on the right elbow joint revealed sarcoid granulomata. These lesions resolved spontaneously 4 months later. The second patient, a 57-year-old male, developed bilateral hilar and mediastinal lymph node enlargement 2 years after finishing IFN-α 2a therapy. A transbronchial lung biopsy demonstrated sarcoid granulomata. In addition, he had uveitis and left ulnar nerve involvement. His eye and nerve involvement gradually improved over 20 months. It is feasible that IFN therapy has been a trigger for sarcoidosis in these patients.

Original languageEnglish
Pages (from-to)529-534
Number of pages6
JournalRespirology
Volume10
Issue number4
DOIs
Publication statusPublished - Sep 2005

Fingerprint

Chronic Hepatitis C
Sarcoidosis
Interferons
Granuloma
Biopsy
Elbow Joint
Ulnar Nerve
Uveitis
Therapeutics
Lymph Nodes
Lung
Skin

Keywords

  • Chronic hepatitis C
  • Granuloma
  • Interferon-α
  • Sarcoidosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Hirano, A., Kataoka, M., Nakata, Y., Takeda, K., Kamao, T., Hiramatsu, J., ... Tanimoto, M. (2005). Sarcoidosis occurring after interferon-α therapy for chronic hepatitis C: Report of two cases. Respirology, 10(4), 529-534. https://doi.org/10.1111/j.1440-1843.2005.00745.x

Sarcoidosis occurring after interferon-α therapy for chronic hepatitis C : Report of two cases. / Hirano, Atsushi; Kataoka, Mikio; Nakata, Yasunari; Takeda, Katsuyuki; Kamao, Takayuki; Hiramatsu, Junichi; Kimura, Goro; Tanimoto, Yasushi; Kanehiro, Arihiko; Tanimoto, Mitsune.

In: Respirology, Vol. 10, No. 4, 09.2005, p. 529-534.

Research output: Contribution to journalArticle

Hirano, A, Kataoka, M, Nakata, Y, Takeda, K, Kamao, T, Hiramatsu, J, Kimura, G, Tanimoto, Y, Kanehiro, A & Tanimoto, M 2005, 'Sarcoidosis occurring after interferon-α therapy for chronic hepatitis C: Report of two cases', Respirology, vol. 10, no. 4, pp. 529-534. https://doi.org/10.1111/j.1440-1843.2005.00745.x
Hirano, Atsushi ; Kataoka, Mikio ; Nakata, Yasunari ; Takeda, Katsuyuki ; Kamao, Takayuki ; Hiramatsu, Junichi ; Kimura, Goro ; Tanimoto, Yasushi ; Kanehiro, Arihiko ; Tanimoto, Mitsune. / Sarcoidosis occurring after interferon-α therapy for chronic hepatitis C : Report of two cases. In: Respirology. 2005 ; Vol. 10, No. 4. pp. 529-534.
@article{4e63db485cc647c1a4553cbadbd372f7,
title = "Sarcoidosis occurring after interferon-α therapy for chronic hepatitis C: Report of two cases",
abstract = "We report two patients who were diagnosed with sarcoidosis after receiving interferon (IFN)-α therapy for chronic hepatitis C, and conduct a review the relevant literature. The first patient was a 52-year-old female who developed multiple subcutaneous nodules 2 months after finishing IFN-α therapy. A skin biopsy from subcutaneous nodules on the right elbow joint revealed sarcoid granulomata. These lesions resolved spontaneously 4 months later. The second patient, a 57-year-old male, developed bilateral hilar and mediastinal lymph node enlargement 2 years after finishing IFN-α 2a therapy. A transbronchial lung biopsy demonstrated sarcoid granulomata. In addition, he had uveitis and left ulnar nerve involvement. His eye and nerve involvement gradually improved over 20 months. It is feasible that IFN therapy has been a trigger for sarcoidosis in these patients.",
keywords = "Chronic hepatitis C, Granuloma, Interferon-α, Sarcoidosis",
author = "Atsushi Hirano and Mikio Kataoka and Yasunari Nakata and Katsuyuki Takeda and Takayuki Kamao and Junichi Hiramatsu and Goro Kimura and Yasushi Tanimoto and Arihiko Kanehiro and Mitsune Tanimoto",
year = "2005",
month = "9",
doi = "10.1111/j.1440-1843.2005.00745.x",
language = "English",
volume = "10",
pages = "529--534",
journal = "Respirology",
issn = "1323-7799",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Sarcoidosis occurring after interferon-α therapy for chronic hepatitis C

T2 - Report of two cases

AU - Hirano, Atsushi

AU - Kataoka, Mikio

AU - Nakata, Yasunari

AU - Takeda, Katsuyuki

AU - Kamao, Takayuki

AU - Hiramatsu, Junichi

AU - Kimura, Goro

AU - Tanimoto, Yasushi

AU - Kanehiro, Arihiko

AU - Tanimoto, Mitsune

PY - 2005/9

Y1 - 2005/9

N2 - We report two patients who were diagnosed with sarcoidosis after receiving interferon (IFN)-α therapy for chronic hepatitis C, and conduct a review the relevant literature. The first patient was a 52-year-old female who developed multiple subcutaneous nodules 2 months after finishing IFN-α therapy. A skin biopsy from subcutaneous nodules on the right elbow joint revealed sarcoid granulomata. These lesions resolved spontaneously 4 months later. The second patient, a 57-year-old male, developed bilateral hilar and mediastinal lymph node enlargement 2 years after finishing IFN-α 2a therapy. A transbronchial lung biopsy demonstrated sarcoid granulomata. In addition, he had uveitis and left ulnar nerve involvement. His eye and nerve involvement gradually improved over 20 months. It is feasible that IFN therapy has been a trigger for sarcoidosis in these patients.

AB - We report two patients who were diagnosed with sarcoidosis after receiving interferon (IFN)-α therapy for chronic hepatitis C, and conduct a review the relevant literature. The first patient was a 52-year-old female who developed multiple subcutaneous nodules 2 months after finishing IFN-α therapy. A skin biopsy from subcutaneous nodules on the right elbow joint revealed sarcoid granulomata. These lesions resolved spontaneously 4 months later. The second patient, a 57-year-old male, developed bilateral hilar and mediastinal lymph node enlargement 2 years after finishing IFN-α 2a therapy. A transbronchial lung biopsy demonstrated sarcoid granulomata. In addition, he had uveitis and left ulnar nerve involvement. His eye and nerve involvement gradually improved over 20 months. It is feasible that IFN therapy has been a trigger for sarcoidosis in these patients.

KW - Chronic hepatitis C

KW - Granuloma

KW - Interferon-α

KW - Sarcoidosis

UR - http://www.scopus.com/inward/record.url?scp=33644839503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644839503&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1843.2005.00745.x

DO - 10.1111/j.1440-1843.2005.00745.x

M3 - Article

VL - 10

SP - 529

EP - 534

JO - Respirology

JF - Respirology

SN - 1323-7799

IS - 4

ER -